Le Lézard
Classified in: Health
Subject: SVY

Dental Bone Grafts & Substitutes Market Size Worth $1.0 Billion by 2026: Grand View Research, Inc.


SAN FRANCISCO, Jan. 21, 2020 /PRNewswire/ -- The global dental bone grafts & substitutes market size is expected to reach USD 1.0 billion by 2026, according to a new report by Grand View Research, Inc., registering a 9.1% CAGR over the forecast period. Increasing target population, rise in dental implant surgical procedures for periodontal diseases and aesthetics, and new product launches are the major growth propellers for the market. Perpetual growth in geriatric population is anticipated to result in a heightened need to curb periodontal diseases, thereby fueling product demand. According to the Population Reference Bureau 2018 statistics, by 2050, around 82 countries across the world are anticipated to have more than 20.0% of their population under the geriatric category (65 years and above).

Grand View Research Logo

Key suggestions from the report:

Read 110 page research report with ToC on "Dental Bone Grafts & Substitutes Market Analysis Report By Material Type (Allograft, Xenograft, Synthetic), By Application (Sinus Lift, Ridge Augmentation), By End Use (Hospitals, Dental Clinics), And Segment Forecasts, 2019 - 2026" at: https://www.grandviewresearch.com/industry-analysis/dental-bone-grafts-substitutes-market

Rising adoption of synthetic grafts over autografts and allografts due to advantages such as lesser chances of disease transmission and better acceptance are further propelling the dental bone graft substitutes market. Furthermore, growing medical tourism in developing countries is expected to fuel the market bone grafts and substitutes. Countries such as South Korea, India, and Turkey are constantly gaining popularity in dental tourism due to cost effective advanced treatment options. In addition, growing number of periodontists and oral surgeons across the globe will boost market demand for dental grafts and biomaterials. Increasing usage of ePTFE and resorbable dental membrane in guided bone regeneration procedures as a part of implant dentistry is anticipated to influence market in near future.

Europe dominated the global market in terms of revenue in 2018. Increasing target population and number of oral implant surgeries performed in this region are driving the market. North America held the second-largest share and is expected to witness steady growth in the coming years. Asia Pacific is expected to exhibit the fastest growth over the forecast period, which can be attributed to increased medical tourism and government initiatives.

Grand View Research has segmented the global dental bone grafts & substitutes market based on material type, application, end use, and region:

Find more research reports on Medical Devices Industry, by Grand View Research:

Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports

About Grand View Research

Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.

Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: +1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter

 

 

SOURCE Grand View Research, Inc.


These press releases may also interest you

at 23:19
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

at 22:15
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

at 21:59
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...

at 21:27
Labcorp , a global leader of innovative and comprehensive laboratory services, announced today that it has been selected as the winning bidder for select assets of Invitae, a leading medical genetics company.  Before the transaction can proceed,...

at 21:19
Invitae , a leading medical genetics company, announced that Labcorp , a global leader of innovative and comprehensive laboratory services, has been selected...

at 21:05
Valcare Medical, Inc., a leading innovator in transcatheter-based mitral...



News published on and distributed by: